International Journal of Drug Discovery and Pharmacology

Scilight Press

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

International Journal of Drug Discovery and Pharmacology is an open-access journal published by Scilight Press in Australia, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,000 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Scilight Press
ISSN
2653-6234
Country
Australia
Languages
english
Access
Open access
Declared publication charge
1,000 USD
Articles in DOAJ
0
Declared review time
16 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2025-09-17
Indexing
DOAJ
APC
1,000 USD
Declared review time (DOAJ)
16 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

0

Average review time (journal-declared via DOAJ)

16weeks

Works in OpenAlex

98

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

8

i10-index

7

From OpenAlex open data (CC0).

Editorial & policy10
Last DOAJ review date
2025-12-04
Added to DOAJ
2025-09-17
Declared plagiarism screening
Not declared
Other fees beyond APC
No
Editorial board
Official page ↗
Open references deposited at Crossref
55%
ORCID iDs in current deposits
0%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9918557485606676
Classification4

Subjects (DOAJ)

Medicine: Therapeutics. PharmacologyScience: Science (General)

LCC codes

RM1-950Q1-390

Subject areas

  • Cardiovascular Function and Risk Factors
  • Cardiovascular Function and Risk Factors
  • Cardiac Fibrosis and Remodeling
  • Receptor Mechanisms and Signaling
  • Receptor Mechanisms and Signaling
  • Cardiac Fibrosis and Remodeling
  • Diabetes Treatment and Management
  • Diabetes Treatment and Management
Show all subjects (50)
  • Heart Failure Treatment and Management
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Cardiac electrophysiology and arrhythmias
  • Cardiac electrophysiology and arrhythmias
  • Heart Failure Treatment and Management
  • Endoplasmic Reticulum Stress and Disease
  • Signaling Pathways in Disease
  • Endoplasmic Reticulum Stress and Disease
  • Signaling Pathways in Disease
  • Atherosclerosis and Cardiovascular Diseases
  • Extracellular vesicles in disease
  • Atherosclerosis and Cardiovascular Diseases
  • Nanoparticle-Based Drug Delivery
  • Cardiomyopathy and Myosin Studies
  • Cardiac Ischemia and Reperfusion
  • Berberine and alkaloids research
  • Berberine and alkaloids research
  • Cardiac Ischemia and Reperfusion
  • Cardiomyopathy and Myosin Studies
  • Protein Degradation and Inhibitors
  • Protein Degradation and Inhibitors
  • Extracellular vesicles in disease
  • Nanoparticle-Based Drug Delivery
  • Ubiquitin and proteasome pathways
  • Ion channel regulation and function
  • MicroRNA in disease regulation
  • Protein Kinase Regulation and GTPase Signaling
  • Ubiquitin and proteasome pathways
  • Acute Myocardial Infarction Research
  • Autophagy in Disease and Therapy
  • Cytokine Signaling Pathways and Interactions
  • Traditional Chinese Medicine Analysis
  • Metabolism, Diabetes, and Cancer
  • MicroRNA in disease regulation
  • Metabolism, Diabetes, and Cancer
  • Ion channel regulation and function
  • Protein Kinase Regulation and GTPase Signaling
  • 3D Printing in Biomedical Research
  • Cytokine Signaling Pathways and Interactions
  • Autophagy in Disease and Therapy
  • Acute Myocardial Infarction Research

Keywords (DOAJ)

  • drug discovery
  • pharmacology
  • biochemistry
  • molecular biology
  • biological agents
  • small molecules agent

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: